|
|
Volumn 16, Issue 1, 2002, Pages 87-99
|
|
Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: Two multicentre, randomized, double-blind studies
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MESALAZINE;
PLACEBO;
RIDOGREL;
THROMBOXANE SYNTHASE;
ADULT;
AGED;
ANEMIA;
ARTICLE;
BACKACHE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
HEADACHE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
META ANALYSIS;
MULTICENTER STUDY;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RASH;
SINUSITIS;
ULCERATIVE COLITIS;
UPPER RESPIRATORY TRACT INFECTION;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
COLITIS, ULCERATIVE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
FEMALE;
GASTROINTESTINAL AGENTS;
HUMANS;
MALE;
MESALAMINE;
MIDDLE AGED;
PENTANOIC ACIDS;
PLACEBOS;
PYRIDINES;
TREATMENT OUTCOME;
|
|
EID: 0036161782
PISSN: 02692813
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2036.2002.01121.x Document Type: Article |
|
Times cited : (27)
|
|
References (18)
|
